Jefferies International and Kempen complete €53.9 million share placing by Galapagos

Client(s) Jefferies International Limited and Kempen & Co N.V.

Jones Day advised Jefferies International Limited and Kempen & Co N.V. in connection with the sale of Ordinary Shares in an accelerated book build placing by Galapagos NV, a clinical stage biotechnology company focused on developing novel medicines. A total of 2,696,831 Ordinary Shares, just under 10% of the Ordinary Shares in Galapagos, were sold at a price of €20.00 per share, raising total gross proceeds of €53.9 million (US$70.2 million) for Galapagos.